Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 69.20
+2.86 (4.31%)
Sep 14, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 41.19 billion as of September 14, 2026. Its market cap has decreased by -6.71% in one year.
Market Cap
41.19B
Enterprise Value
37.68B
Revenue
4.21B
Ranking
n/a
PE Ratio
35.67
Stock Price
69.20
ChartMarket Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 41.19B, an increase of 12.62%. That is a compound annual growth rate of 1.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 41.19B | 1.66% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intco Medical Technology | 35.62B |
| iRay Group | 27.63B |
| Imeik Technology Development | 26.66B |
| Andon Health | 25.76B |
| Zhende Medical | 21.43B |
| Winner Medical | 16.37B |
| Micro-Tech (Nanjing) Co.,Ltd | 13.73B |
| Shenyang Xingqi Pharmaceutical | 12.94B |